Tower Research Capital LLC (Trc) Allovir, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Allovir, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 17,449 shares of ALVR stock, worth $166,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,449

Previous 2,319 652.44%

Holding current value

$166,986

Previous $1,000 600.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.4 - $1.01 $6,052 - $15,281	15,130 Added 652.44%	17,449 $7,000
Q3 2024 Nov 14, 2024	SELL	$0.7 - $0.82 $12,767 - $14,955	-18,239 Reduced 88.72%	2,319 $1,000
Q2 2024 Aug 13, 2024	BUY	$0.72 - $0.82 $7,477 - $8,516	10,386 Added 102.1%	20,558 $14,000
Q1 2024 May 15, 2024	SELL	$0.64 - $0.78 $2,746 - $3,346	-4,291 Reduced 29.67%	10,172 $7,000
Q4 2023 Feb 13, 2024	BUY	$0.68 - $2.39 $5,490 - $19,296	8,074 Added 126.37%	14,463 $9,000
Q3 2023 Nov 14, 2023	SELL	$2.15 - $3.64 $5,015 - $8,492	-2,333 Reduced 26.75%	6,389 $13,000
Q2 2023 Aug 14, 2023	BUY	$3.17 - $5.82 $21,001 - $38,557	6,625 Added 315.93%	8,722 $29,000
Q1 2023 May 09, 2023	SELL	$3.94 - $7.05 $21,993 - $39,353	-5,582 Reduced 72.69%	2,097 $8,000
Q4 2022 Feb 10, 2023	BUY	$4.7 - $9.98 $22,122 - $46,975	4,707 Added 158.38%	7,679 $39,000
Q3 2022 Nov 10, 2022	SELL	$4.13 - $8.79 $14,925 - $31,767	-3,614 Reduced 54.87%	2,972 $23,000
Q2 2022 Aug 15, 2022	BUY	$3.26 - $7.06 $3,687 - $7,984	1,131 Added 20.73%	6,586 $26,000
Q1 2022 May 12, 2022	BUY	$6.75 - $13.52 $16,119 - $32,285	2,388 Added 77.86%	5,455 $37,000
Q4 2021 Feb 14, 2022	BUY	$12.94 - $25.99 $7,375 - $14,814	570 Added 22.83%	3,067 $40,000
Q3 2021 Nov 15, 2021	BUY	$16.97 - $25.06 $5,294 - $7,818	312 Added 14.28%	2,497 $63,000
Q2 2021 Aug 16, 2021	BUY	$19.44 - $25.06 $10,497 - $13,532	540 Added 32.83%	2,185 $43,000
Q1 2021 May 17, 2021	SELL	$20.81 - $45.5 $86,611 - $189,371	-4,162 Reduced 71.67%	1,645 $38,000
Q4 2020 Feb 16, 2021	BUY	$23.94 - $46.81 $51,207 - $100,126	2,139 Added 58.32%	5,807 $223,000
Q3 2020 Nov 16, 2020	BUY	$21.05 - $42.7 $77,211 - $156,623	3,668 New	3,668 $101,000

Others Institutions Holding ALVR

# of Institutions

Shares Held

21.1M

Call Options Held

41K

Put Options Held

100

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $891M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Allovir, Inc. Transaction History